nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—HTR3A—autistic disorder	0.245	0.313	CbGaD
Sumatriptan—HTR1D—autistic disorder	0.243	0.31	CbGaD
Sumatriptan—MAOA—autistic disorder	0.151	0.193	CbGaD
Sumatriptan—HTR1B—autistic disorder	0.144	0.184	CbGaD
Sumatriptan—HTR1B—telencephalic ventricle—autistic disorder	0.00402	0.057	CbGeAlD
Sumatriptan—HTR1D—telencephalic ventricle—autistic disorder	0.0039	0.0552	CbGeAlD
Sumatriptan—HTR1A—telencephalic ventricle—autistic disorder	0.00325	0.046	CbGeAlD
Sumatriptan—DRD2—telencephalic ventricle—autistic disorder	0.00293	0.0416	CbGeAlD
Sumatriptan—HTR1F—forebrain—autistic disorder	0.00256	0.0363	CbGeAlD
Sumatriptan—HTR1F—telencephalon—autistic disorder	0.00236	0.0334	CbGeAlD
Sumatriptan—HTR1A—hindbrain—autistic disorder	0.00153	0.0217	CbGeAlD
Sumatriptan—HTR1F—head—autistic disorder	0.00147	0.0208	CbGeAlD
Sumatriptan—MAOA—hindbrain—autistic disorder	0.0014	0.0198	CbGeAlD
Sumatriptan—HTR1F—nervous system—autistic disorder	0.00139	0.0197	CbGeAlD
Sumatriptan—DRD2—hindbrain—autistic disorder	0.00139	0.0196	CbGeAlD
Sumatriptan—Melatonin—ASMT—autistic disorder	0.00136	0.172	CrCbGaD
Sumatriptan—HTR1F—central nervous system—autistic disorder	0.00134	0.019	CbGeAlD
Sumatriptan—HTR3A—brainstem—autistic disorder	0.0013	0.0184	CbGeAlD
Sumatriptan—HTR3A—forebrain—autistic disorder	0.00125	0.0177	CbGeAlD
Sumatriptan—HTR3A—telencephalon—autistic disorder	0.00115	0.0163	CbGeAlD
Sumatriptan—HTR1B—brainstem—autistic disorder	0.00109	0.0154	CbGeAlD
Sumatriptan—HTR1F—brain—autistic disorder	0.00106	0.0151	CbGeAlD
Sumatriptan—HTR1D—brainstem—autistic disorder	0.00105	0.0149	CbGeAlD
Sumatriptan—HTR1B—forebrain—autistic disorder	0.00105	0.0149	CbGeAlD
Sumatriptan—HTR1D—eye—autistic disorder	0.00103	0.0145	CbGeAlD
Sumatriptan—HTR1D—forebrain—autistic disorder	0.00102	0.0144	CbGeAlD
Sumatriptan—SLCO1A2—forebrain—autistic disorder	0.000989	0.014	CbGeAlD
Sumatriptan—HTR1B—telencephalon—autistic disorder	0.000966	0.0137	CbGeAlD
Sumatriptan—HTR1D—telencephalon—autistic disorder	0.000936	0.0133	CbGeAlD
Sumatriptan—SLCO1A2—telencephalon—autistic disorder	0.000909	0.0129	CbGeAlD
Sumatriptan—HTR3A—digestive system—autistic disorder	0.000879	0.0125	CbGeAlD
Sumatriptan—HTR1A—brainstem—autistic disorder	0.000879	0.0124	CbGeAlD
Sumatriptan—SLCO1B1—digestive system—autistic disorder	0.000853	0.0121	CbGeAlD
Sumatriptan—HTR1A—forebrain—autistic disorder	0.000848	0.012	CbGeAlD
Sumatriptan—Naratriptan—HTR1D—autistic disorder	0.000824	0.105	CrCbGaD
Sumatriptan—MAOA—brainstem—autistic disorder	0.000803	0.0114	CbGeAlD
Sumatriptan—DRD2—brainstem—autistic disorder	0.000794	0.0112	CbGeAlD
Sumatriptan—HTR1A—telencephalon—autistic disorder	0.00078	0.011	CbGeAlD
Sumatriptan—MAOA—forebrain—autistic disorder	0.000775	0.011	CbGeAlD
Sumatriptan—DRD2—eye—autistic disorder	0.000773	0.0109	CbGeAlD
Sumatriptan—DRD2—forebrain—autistic disorder	0.000766	0.0109	CbGeAlD
Sumatriptan—HTR3A—head—autistic disorder	0.000717	0.0102	CbGeAlD
Sumatriptan—MAOA—telencephalon—autistic disorder	0.000712	0.0101	CbGeAlD
Sumatriptan—DRD2—telencephalon—autistic disorder	0.000705	0.00998	CbGeAlD
Sumatriptan—SLCO1A2—digestive system—autistic disorder	0.000694	0.00983	CbGeAlD
Sumatriptan—Rizatriptan—HTR1D—autistic disorder	0.000683	0.0867	CrCbGaD
Sumatriptan—HTR3A—nervous system—autistic disorder	0.00068	0.00963	CbGeAlD
Sumatriptan—HTR3A—central nervous system—autistic disorder	0.000655	0.00927	CbGeAlD
Sumatriptan—Zolmitriptan—HTR1D—autistic disorder	0.000625	0.0793	CrCbGaD
Sumatriptan—ABCG2—telencephalon—autistic disorder	0.000618	0.00875	CbGeAlD
Sumatriptan—HTR1B—head—autistic disorder	0.000602	0.00852	CbGeAlD
Sumatriptan—HTR1D—head—autistic disorder	0.000583	0.00825	CbGeAlD
Sumatriptan—HTR1B—nervous system—autistic disorder	0.00057	0.00808	CbGeAlD
Sumatriptan—SLCO1A2—head—autistic disorder	0.000566	0.00802	CbGeAlD
Sumatriptan—HTR1D—nervous system—autistic disorder	0.000552	0.00782	CbGeAlD
Sumatriptan—HTR1B—central nervous system—autistic disorder	0.000549	0.00778	CbGeAlD
Sumatriptan—MAOA—digestive system—autistic disorder	0.000544	0.0077	CbGeAlD
Sumatriptan—SLCO1A2—nervous system—autistic disorder	0.000537	0.0076	CbGeAlD
Sumatriptan—HTR1D—central nervous system—autistic disorder	0.000532	0.00753	CbGeAlD
Sumatriptan—HTR3A—brain—autistic disorder	0.00052	0.00736	CbGeAlD
Sumatriptan—SLCO1A2—central nervous system—autistic disorder	0.000517	0.00732	CbGeAlD
Sumatriptan—Naratriptan—MAOA—autistic disorder	0.000512	0.065	CrCbGaD
Sumatriptan—SLCO1A2—cerebellum—autistic disorder	0.000505	0.00715	CbGeAlD
Sumatriptan—Naratriptan—HTR1B—autistic disorder	0.000489	0.0621	CrCbGaD
Sumatriptan—HTR1A—head—autistic disorder	0.000486	0.00688	CbGeAlD
Sumatriptan—Almotriptan—HTR1D—autistic disorder	0.000473	0.0601	CrCbGaD
Sumatriptan—HTR1A—nervous system—autistic disorder	0.00046	0.00652	CbGeAlD
Sumatriptan—MAOA—head—autistic disorder	0.000444	0.00628	CbGeAlD
Sumatriptan—HTR1A—central nervous system—autistic disorder	0.000443	0.00628	CbGeAlD
Sumatriptan—DRD2—head—autistic disorder	0.000439	0.00622	CbGeAlD
Sumatriptan—HTR1B—brain—autistic disorder	0.000436	0.00618	CbGeAlD
Sumatriptan—HTR1A—cerebellum—autistic disorder	0.000433	0.00614	CbGeAlD
Sumatriptan—Rizatriptan—MAOA—autistic disorder	0.000425	0.0539	CrCbGaD
Sumatriptan—HTR1D—brain—autistic disorder	0.000422	0.00598	CbGeAlD
Sumatriptan—MAOA—nervous system—autistic disorder	0.000421	0.00596	CbGeAlD
Sumatriptan—DRD2—nervous system—autistic disorder	0.000416	0.00589	CbGeAlD
Sumatriptan—SLCO1A2—brain—autistic disorder	0.00041	0.00581	CbGeAlD
Sumatriptan—Rizatriptan—HTR1B—autistic disorder	0.000405	0.0514	CrCbGaD
Sumatriptan—MAOA—central nervous system—autistic disorder	0.000405	0.00574	CbGeAlD
Sumatriptan—DRD2—central nervous system—autistic disorder	0.0004	0.00567	CbGeAlD
Sumatriptan—MAOA—cerebellum—autistic disorder	0.000396	0.00561	CbGeAlD
Sumatriptan—DRD2—cerebellum—autistic disorder	0.000391	0.00555	CbGeAlD
Sumatriptan—Zolmitriptan—MAOA—autistic disorder	0.000388	0.0493	CrCbGaD
Sumatriptan—Zolmitriptan—HTR1B—autistic disorder	0.000371	0.047	CrCbGaD
Sumatriptan—Eletriptan—HTR1D—autistic disorder	0.000369	0.0468	CrCbGaD
Sumatriptan—HTR1A—brain—autistic disorder	0.000352	0.00498	CbGeAlD
Sumatriptan—ABCG2—cerebellum—autistic disorder	0.000343	0.00486	CbGeAlD
Sumatriptan—ABCB1—forebrain—autistic disorder	0.000331	0.00469	CbGeAlD
Sumatriptan—MAOA—brain—autistic disorder	0.000321	0.00455	CbGeAlD
Sumatriptan—DRD2—brain—autistic disorder	0.000318	0.0045	CbGeAlD
Sumatriptan—ABCB1—telencephalon—autistic disorder	0.000305	0.00431	CbGeAlD
Sumatriptan—Almotriptan—MAOA—autistic disorder	0.000294	0.0374	CrCbGaD
Sumatriptan—Almotriptan—HTR1B—autistic disorder	0.000281	0.0357	CrCbGaD
Sumatriptan—ABCG2—brain—autistic disorder	0.000279	0.00395	CbGeAlD
Sumatriptan—ABCB1—digestive system—autistic disorder	0.000232	0.00329	CbGeAlD
Sumatriptan—Eletriptan—HTR1B—autistic disorder	0.000219	0.0278	CrCbGaD
Sumatriptan—ABCB1—head—autistic disorder	0.00019	0.00269	CbGeAlD
Sumatriptan—ABCB1—nervous system—autistic disorder	0.00018	0.00255	CbGeAlD
Sumatriptan—ABCB1—central nervous system—autistic disorder	0.000173	0.00245	CbGeAlD
Sumatriptan—ABCB1—cerebellum—autistic disorder	0.000169	0.0024	CbGeAlD
Sumatriptan—Melatonin—CYP19A1—autistic disorder	0.000164	0.0209	CrCbGaD
Sumatriptan—ABCB1—brain—autistic disorder	0.000137	0.00195	CbGeAlD
Sumatriptan—HTR1A—GPCR downstream signaling—HTR2A—autistic disorder	9.94e-06	7.17e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MAOA—autistic disorder	9.93e-06	7.16e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	9.91e-06	7.14e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—XDH—autistic disorder	9.84e-06	7.09e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PRKCB—autistic disorder	9.8e-06	7.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADM—autistic disorder	9.8e-06	7.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GABBR1—autistic disorder	9.8e-06	7.06e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CAT—autistic disorder	9.69e-06	6.99e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—POMC—autistic disorder	9.67e-06	6.97e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—STX1A—autistic disorder	9.66e-06	6.96e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NPAS2—autistic disorder	9.66e-06	6.96e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRL—autistic disorder	9.64e-06	6.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GZMB—autistic disorder	9.63e-06	6.95e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EIF4E—autistic disorder	9.63e-06	6.94e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PDE4B—autistic disorder	9.55e-06	6.88e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AVP—autistic disorder	9.53e-06	6.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—POMC—autistic disorder	9.47e-06	6.82e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRL—autistic disorder	9.44e-06	6.81e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—APC—autistic disorder	9.38e-06	6.76e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CG—autistic disorder	9.38e-06	6.76e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—OXT—autistic disorder	9.35e-06	6.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR1B—autistic disorder	9.35e-06	6.74e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TCN2—autistic disorder	9.33e-06	6.72e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGF—autistic disorder	9.27e-06	6.69e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—COMT—autistic disorder	9.27e-06	6.68e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—OPRM1—autistic disorder	9.25e-06	6.67e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTP1—autistic disorder	9.23e-06	6.65e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP19A1—autistic disorder	9.2e-06	6.63e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTM1—autistic disorder	9.15e-06	6.6e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PLA2G4A—autistic disorder	9.15e-06	6.6e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADRB2—autistic disorder	9.15e-06	6.59e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HTR2A—autistic disorder	9.03e-06	6.51e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CAT—autistic disorder	8.98e-06	6.47e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PLA2G4A—autistic disorder	8.96e-06	6.46e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADRB2—autistic disorder	8.96e-06	6.46e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—POMC—autistic disorder	8.93e-06	6.44e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ADA—autistic disorder	8.9e-06	6.42e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	8.9e-06	6.41e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GPX1—autistic disorder	8.76e-06	6.32e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR2A—autistic disorder	8.73e-06	6.29e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PRKCB—autistic disorder	8.72e-06	6.28e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD1—autistic disorder	8.7e-06	6.27e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC1—autistic disorder	8.7e-06	6.27e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	8.64e-06	6.23e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AVP—autistic disorder	8.59e-06	6.2e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1—autistic disorder	8.59e-06	6.19e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF2—autistic disorder	8.56e-06	6.17e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—COMT—autistic disorder	8.56e-06	6.17e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—MAPK1—autistic disorder	8.55e-06	6.16e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP19A1—autistic disorder	8.52e-06	6.14e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTP1—autistic disorder	8.52e-06	6.14e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MAOA—autistic disorder	8.5e-06	6.12e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTM1—autistic disorder	8.48e-06	6.11e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PLA2G4A—autistic disorder	8.48e-06	6.11e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GZMB—autistic disorder	8.46e-06	6.1e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NTRK2—autistic disorder	8.46e-06	6.1e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD3—autistic disorder	8.42e-06	6.07e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	8.42e-06	6.07e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AVP—autistic disorder	8.42e-06	6.07e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF2—autistic disorder	8.38e-06	6.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CG—autistic disorder	8.34e-06	6.01e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CAT—autistic disorder	8.29e-06	5.97e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL5—autistic disorder	8.24e-06	5.94e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR1B—autistic disorder	8.21e-06	5.92e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—OXT—autistic disorder	8.21e-06	5.92e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SERPINE1—autistic disorder	8.16e-06	5.88e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CALCA—autistic disorder	8.14e-06	5.87e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GPX1—autistic disorder	8.12e-06	5.85e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—RORA—autistic disorder	8.12e-06	5.85e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MTHFR—autistic disorder	8.09e-06	5.83e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PLA2G4A—autistic disorder	8.08e-06	5.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—POMC—autistic disorder	7.94e-06	5.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR2A—autistic disorder	7.93e-06	5.72e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—COMT—autistic disorder	7.92e-06	5.71e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PRKCB—autistic disorder	7.92e-06	5.71e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PLA2G4A—autistic disorder	7.91e-06	5.7e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTP1—autistic disorder	7.88e-06	5.68e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2—autistic disorder	7.87e-06	5.67e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MAOA—autistic disorder	7.87e-06	5.67e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MEF2C—autistic disorder	7.86e-06	5.67e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PLA2G4A—autistic disorder	7.83e-06	5.64e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTM1—autistic disorder	7.83e-06	5.64e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2—autistic disorder	7.71e-06	5.56e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MEF2C—autistic disorder	7.7e-06	5.55e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CAT—autistic disorder	7.67e-06	5.53e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ITGB3—autistic disorder	7.66e-06	5.52e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PRKCB—autistic disorder	7.65e-06	5.52e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD1—autistic disorder	7.63e-06	5.5e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC1—autistic disorder	7.63e-06	5.5e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MAOB—autistic disorder	7.6e-06	5.48e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CG—autistic disorder	7.58e-06	5.46e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—APOE—autistic disorder	7.53e-06	5.43e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ITGB3—autistic disorder	7.5e-06	5.41e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—MTHFR—autistic disorder	7.49e-06	5.4e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GPX1—autistic disorder	7.49e-06	5.4e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NTRK2—autistic disorder	7.43e-06	5.35e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD3—autistic disorder	7.39e-06	5.33e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CG—autistic disorder	7.32e-06	5.28e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTM1—autistic disorder	7.25e-06	5.22e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PLA2G4A—autistic disorder	7.25e-06	5.22e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL5—autistic disorder	7.24e-06	5.22e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—POMC—autistic disorder	7.21e-06	5.2e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRL—autistic disorder	7.19e-06	5.18e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR2A—autistic disorder	7.15e-06	5.16e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CALCA—autistic disorder	7.15e-06	5.15e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2—autistic disorder	7.15e-06	5.15e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TPH2—autistic disorder	7.07e-06	5.1e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR2A—autistic disorder	7e-06	5.05e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2—autistic disorder	7e-06	5.05e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOE—autistic disorder	6.98e-06	5.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—POMC—autistic disorder	6.97e-06	5.03e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DPYD—autistic disorder	6.96e-06	5.01e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PRKCB—autistic disorder	6.95e-06	5.01e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GPX1—autistic disorder	6.94e-06	5e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MTHFR—autistic disorder	6.92e-06	4.99e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HRAS—autistic disorder	6.86e-06	4.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRB2—autistic disorder	6.82e-06	4.92e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CG—autistic disorder	6.8e-06	4.9e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TSC2—autistic disorder	6.79e-06	4.9e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TSC2—autistic disorder	6.65e-06	4.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CG—autistic disorder	6.65e-06	4.8e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—LEP—autistic disorder	6.65e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOE—autistic disorder	6.65e-06	4.79e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2—autistic disorder	6.6e-06	4.76e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—autistic disorder	6.57e-06	4.74e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—LEP—autistic disorder	6.51e-06	4.69e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOE—autistic disorder	6.51e-06	4.69e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—POMC—autistic disorder	6.47e-06	4.66e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CACNA1C—autistic disorder	6.47e-06	4.66e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOE—autistic disorder	6.44e-06	4.64e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AVP—autistic disorder	6.41e-06	4.62e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTHFR—autistic disorder	6.4e-06	4.62e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF2—autistic disorder	6.38e-06	4.6e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—POMC—autistic disorder	6.33e-06	4.56e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRL—autistic disorder	6.31e-06	4.55e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CG—autistic disorder	6.3e-06	4.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRKCB—autistic disorder	6.27e-06	4.52e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTEN—autistic disorder	6.21e-06	4.48e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRKCB—autistic disorder	6.14e-06	4.43e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PLA2G4A—autistic disorder	6.03e-06	4.34e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APC—autistic disorder	6e-06	4.33e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CG—autistic disorder	6e-06	4.33e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—POMC—autistic disorder	5.99e-06	4.32e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRB2—autistic disorder	5.99e-06	4.32e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOE—autistic disorder	5.96e-06	4.3e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGF—autistic disorder	5.93e-06	4.28e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DHFR—autistic disorder	5.88e-06	4.24e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CG—autistic disorder	5.87e-06	4.24e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APC—autistic disorder	5.87e-06	4.24e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2—autistic disorder	5.87e-06	4.23e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MEF2C—autistic disorder	5.86e-06	4.23e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CG—autistic disorder	5.81e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGF—autistic disorder	5.81e-06	4.19e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ITGB3—autistic disorder	5.71e-06	4.12e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—POMC—autistic disorder	5.71e-06	4.12e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AVP—autistic disorder	5.63e-06	4.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF2—autistic disorder	5.6e-06	4.04e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—POMC—autistic disorder	5.59e-06	4.03e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—POMC—autistic disorder	5.53e-06	3.99e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—autistic disorder	5.49e-06	3.96e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—MAPK1—autistic disorder	5.47e-06	3.94e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CG—autistic disorder	5.38e-06	3.88e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—autistic disorder	5.38e-06	3.88e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—MAPK1—autistic disorder	5.35e-06	3.86e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—autistic disorder	5.33e-06	3.85e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—autistic disorder	5.33e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PLA2G4A—autistic disorder	5.29e-06	3.81e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SERPINE1—autistic disorder	5.22e-06	3.76e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—autistic disorder	5.16e-06	3.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—autistic disorder	5.15e-06	3.72e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MEF2C—autistic disorder	5.15e-06	3.71e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—autistic disorder	5.12e-06	3.69e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SERPINE1—autistic disorder	5.11e-06	3.68e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC2—autistic disorder	5.07e-06	3.65e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK1—autistic disorder	5.05e-06	3.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ITGB3—autistic disorder	5.02e-06	3.62e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—LEP—autistic disorder	4.96e-06	3.57e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOE—autistic disorder	4.96e-06	3.57e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—autistic disorder	4.78e-06	3.45e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—autistic disorder	4.68e-06	3.38e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—autistic disorder	4.68e-06	3.37e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKCB—autistic disorder	4.68e-06	3.37e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP19A1—autistic disorder	4.61e-06	3.32e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—autistic disorder	4.5e-06	3.24e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APC—autistic disorder	4.48e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CG—autistic disorder	4.48e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC2—autistic disorder	4.45e-06	3.21e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGF—autistic disorder	4.42e-06	3.19e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—autistic disorder	4.41e-06	3.18e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRAS—autistic disorder	4.39e-06	3.16e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—LEP—autistic disorder	4.35e-06	3.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOE—autistic disorder	4.35e-06	3.14e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRAS—autistic disorder	4.3e-06	3.1e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—COMT—autistic disorder	4.28e-06	3.09e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—autistic disorder	4.26e-06	3.07e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—autistic disorder	4.26e-06	3.07e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MAOA—autistic disorder	4.25e-06	3.07e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—autistic disorder	4.22e-06	3.04e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—autistic disorder	4.2e-06	3.03e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—autistic disorder	4.17e-06	3.01e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAT—autistic disorder	4.15e-06	2.99e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—autistic disorder	4.13e-06	2.98e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—autistic disorder	4.11e-06	2.97e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCB—autistic disorder	4.11e-06	2.96e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—autistic disorder	4.1e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—autistic disorder	4.08e-06	2.94e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	4.08e-06	2.94e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRAS—autistic disorder	4.05e-06	2.92e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—autistic disorder	3.97e-06	2.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CG—autistic disorder	3.93e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APC—autistic disorder	3.93e-06	2.83e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PLA2G4A—autistic disorder	3.92e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—autistic disorder	3.92e-06	2.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	3.89e-06	2.81e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—autistic disorder	3.89e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGF—autistic disorder	3.88e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—autistic disorder	3.88e-06	2.8e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—autistic disorder	3.85e-06	2.77e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—autistic disorder	3.75e-06	2.7e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—autistic disorder	3.74e-06	2.7e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—autistic disorder	3.6e-06	2.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK1—autistic disorder	3.58e-06	2.58e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—autistic disorder	3.56e-06	2.57e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—autistic disorder	3.46e-06	2.5e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SERPINE1—autistic disorder	3.42e-06	2.46e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRAS—autistic disorder	3.27e-06	2.36e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK1—autistic disorder	3.23e-06	2.33e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOE—autistic disorder	3.22e-06	2.32e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK1—autistic disorder	3.16e-06	2.28e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—autistic disorder	3.15e-06	2.27e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—autistic disorder	3.13e-06	2.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—autistic disorder	2.96e-06	2.14e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CG—autistic disorder	2.91e-06	2.1e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRAS—autistic disorder	2.87e-06	2.07e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—autistic disorder	2.77e-06	2e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—autistic disorder	2.77e-06	1.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—autistic disorder	2.75e-06	1.98e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—autistic disorder	2.6e-06	1.88e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRAS—autistic disorder	2.59e-06	1.87e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRAS—autistic disorder	2.54e-06	1.83e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—autistic disorder	2.48e-06	1.79e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—autistic disorder	2.43e-06	1.75e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK1—autistic disorder	2.41e-06	1.74e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—autistic disorder	2.21e-06	1.59e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK1—autistic disorder	2.12e-06	1.52e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRAS—autistic disorder	1.93e-06	1.39e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—autistic disorder	1.93e-06	1.39e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—autistic disorder	1.85e-06	1.33e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRAS—autistic disorder	1.7e-06	1.22e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—autistic disorder	1.63e-06	1.17e-05	CbGpPWpGaD
